Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Net Cash Flow (2020 - 2025)

Biofrontera (BFRI) has 6 years of Net Cash Flow data on record, last reported at -$3.8 million in Q3 2025.

  • For Q3 2025, Net Cash Flow fell 144.62% year-over-year to -$3.8 million; the TTM value through Sep 2025 reached -$8.0 million, down 1239.06%, while the annual FY2024 figure was $4.5 million, 128.57% up from the prior year.
  • Net Cash Flow reached -$3.8 million in Q3 2025 per BFRI's latest filing, down from -$3.1 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $22.8 million in Q4 2021 and bottomed at -$10.4 million in Q4 2022.
  • Average Net Cash Flow over 5 years is -$1.2 million, with a median of -$2.1 million recorded in 2023.
  • Peak YoY movement for Net Cash Flow: soared 525.82% in 2021, then plummeted 10879.79% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at $22.8 million in 2021, then crashed by 145.42% to -$10.4 million in 2022, then soared by 79.93% to -$2.1 million in 2023, then surged by 246.66% to $3.0 million in 2024, then tumbled by 224.6% to -$3.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were -$3.8 million in Q3 2025, -$3.1 million in Q2 2025, and -$4.1 million in Q1 2025.